文献速递慢性肾脏病血液净化与透析水电解质与酸碱

西那卡塞用于婴幼儿透析患者:把握时机、剂量与适用人群

Cinacalcet for Infants and Young Children on Maintenance Dialysis: Determining the Right Time, the Right Dose and the Right Patients.
PubMed 文献 · Kidney Int Rep · 2024-11-29

本文综述西那卡塞在儿童透析患者尤其是3岁以下婴幼儿中控制继发性或三发性甲状旁腺功能亢进的现有证据。尽管该药在成人和年长儿童中安全有效,但低龄透析患儿数据匮乏,本文讨论管理要点并提供实用用药思路。

要点

  • 西那卡塞在成人和年长儿童中可安全控制甲状旁腺功能亢进。
  • 3岁以下透析婴幼儿使用西那卡塞的证据有限。
  • 本文为低龄透析患儿使用西那卡塞提供实用管理思路。

核心结论

  • 西那卡塞是控制儿童透析患者甲状旁腺功能亢进的有前景选择,但低龄婴幼儿需更多数据指导用药。

研究设计与样本

  • 本文为综述,汇总西那卡塞在儿童透析患者尤其是3岁以下婴幼儿中使用的现有证据。

主要发现

  • 常规治疗下部分透析患儿仍出现继发性甚至三发性甲状旁腺功能亢进。
  • 西那卡塞在成人和年长儿童中安全性可接受。
  • 3岁以下透析婴幼儿使用西那卡塞的数据和指导匮乏。

临床怎么用

  • 对常规治疗控制不佳的透析患儿可考虑西那卡塞,但低龄婴幼儿需个体化评估时机与剂量。

局限性

  • 低龄婴幼儿使用西那卡塞的证据有限,缺乏专门指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) is a recognized complication of kidney failure, which can lead to short stature, bone deformity, slipped capital femoral epiphysis, and bone fracture in children. Despite the use of conventional therapies, a subgroup of patients receiving dialysis continues to experience secondary or even tertiary hyperparathyroidism. Cinacalcet, a calcimimetic agent, has been shown to be a promising therapeutic option to control hyperparathyroidism with reasonable safety profiles in adults and older children. Nevertheless, there is a paucity of data and guidance pertaining to its use among the younger children on dialysis, who are often the most challenging patients to manage with severe CKD-MBD. In this review, we summarize the available evidence on cinacalcet use among pediatric patients, especially infants and young children aged < 3 years. We also discuss the unique considerations in management and attempt to provide a pragmatic approach regarding the use of cinacalcet in this specific patient population.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Lin KY, Lai FF, Chan EY, et al. Cinacalcet for Infants and Young Children on Maintenance Dialysis: Determining the Right Time, the Right Dose and the Right Patients. Kidney Int Rep. 2024. PMID: 40225398. doi:10.1016/j.ekir.2024.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。